wikimedia
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Triples
Insights
Schema
BETA
Class frequency
Class hierarchy
SPARQL
GraphQL
BETA
Graphs
1
Q35943499-8C60A684-70C3-42B4-9726-68386515079D
Q35943499-8C60A684-70C3-42B4-9726-68386515079D
BestRank
Statement
http://www.wikidata.org/entity/statement/Q35943499-8C60A684-70C3-42B4-9726-68386515079D
Aflibercept, Bevacizumab, or Ranibizumab for Diabetic Macular Edema: Two-Year Results from a Comparative Effectiveness Randomized Clinical Trial.
P2860
Q35943499-8C60A684-70C3-42B4-9726-68386515079D
BestRank
Statement
http://www.wikidata.org/entity/statement/Q35943499-8C60A684-70C3-42B4-9726-68386515079D
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
3238864e02d764d3248c17a473f7c6f5b200cd8e
P2860
Intravitreal Aflibercept for Diabetic Macular Edema: 100-Week Results From the VISTA and VIVID Studies.